PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Sep-2025 Aera Therapeutics Appoints Bill Querbes, Ph.D., as Chief Scientific Officer Businesswire
02-Sep-2025 Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer Businesswire
02-Sep-2025 Neucore Bio Awarded U.S. National Institutes of Health (NIH) STTR Phase I Grant to Pursue Exosome-based Genetic Medicine for Charcot-Marie-Tooth Disease Type 1A (CMT1A) Businesswire
02-Sep-2025 Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome Businesswire
02-Sep-2025 Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome Businesswire
02-Sep-2025 Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference Businesswire
02-Sep-2025 United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis Businesswire
02-Sep-2025 Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study Businesswire
02-Sep-2025 Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder Businesswire
02-Sep-2025 Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Businesswire
02-Sep-2025 ICON plc to Participate at Upcoming Investor Conferences Businesswire
02-Sep-2025 US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively Businesswire
02-Sep-2025 Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars Businesswire
02-Sep-2025 Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy Businesswire
02-Sep-2025 QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing Businesswire
02-Sep-2025 Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025 Businesswire
02-Sep-2025 Long-Acting Drug Delivery Technologies and Services Market Industry Trends and Global Forecasts to 2035: Over 1,200 Patents Filed in Long-Acting Drug Delivery Technologies - ResearchAndMarkets.com Businesswire
01-Sep-2025 Smart Medical Devices Global Markets Report 2025 | Sales Data for 2022-2024, Estimates for 2025, and CAGR Projections Through 2030 - ResearchAndMarkets.com Businesswire
01-Sep-2025 Digital Biomarkers Global Markets Report 2025-2030 with Profiles of Leading Players - Actigraph, AliveCor, Altoida, Evidation Health, and IXICO - ResearchAndMarkets.com Businesswire
01-Sep-2025 STAT Inhibitors Pipeline Market Insights Report 2025 | 18 Companies and 22 Pipeline Drugs in Stages Ranging from Clinical to Nonclinical - ResearchAndMarkets.com Businesswire